Prevalence of chronic kidney disease and associated risk factors--United States, 1999-2004 - PubMed (original) (raw)
. 2007 Mar 2;56(8):161-5.
- PMID: 17332726
Free article
Prevalence of chronic kidney disease and associated risk factors--United States, 1999-2004
Centers for Disease Control and Prevention (CDC). MMWR Morb Mortal Wkly Rep. 2007.
Free article
Abstract
Chronic kidney disease (CKD) is a serious condition associated with premature mortality, decreased quality of life, and increased health-care expenditures. Untreated CKD can result in end-stage renal disease and necessitate dialysis or kidney transplantation. Risk factors for CKD include cardiovascular disease, diabetes, hypertension, and obesity. To estimate the prevalence of CKD in the United States (overall and by health risk factors and other characteristics), CDC analyzed the most recent data from the National Health and Nutrition Examination Survey (NHANES). This report summarizes the results of that analysis, which determined that 16.8% of the U.S. population aged >/=20 years had CKD, according to 1999-2004 NHANES data, compared with 14.5% from the 1988-1994 NHANES (i.e., NHANES III), an increase of 15.9% based on crude estimates of prevalence. Persons with diabetes or cardiovascular disease had a greater prevalence of CKD than persons without those conditions. The results underscore the need to continue surveillance for CKD and its risk factors in the United States and to implement new strategies to reduce the number of persons with this condition.
Similar articles
- CKD in the United States: Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES) 1999-2004.
Whaley-Connell AT, Sowers JR, Stevens LA, McFarlane SI, Shlipak MG, Norris KC, Chen SC, Qiu Y, Wang C, Li S, Vassalotti JA, Collins AJ; Kidney Early Evaluation Program Investigators. Whaley-Connell AT, et al. Am J Kidney Dis. 2008 Apr;51(4 Suppl 2):S13-20. doi: 10.1053/j.ajkd.2007.12.016. Am J Kidney Dis. 2008. PMID: 18359403 - Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey.
Coresh J, Astor BC, Greene T, Eknoyan G, Levey AS. Coresh J, et al. Am J Kidney Dis. 2003 Jan;41(1):1-12. doi: 10.1053/ajkd.2003.50007. Am J Kidney Dis. 2003. PMID: 12500213 - Hypertension and CKD: Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES), 1999-2004.
Rao MV, Qiu Y, Wang C, Bakris G. Rao MV, et al. Am J Kidney Dis. 2008 Apr;51(4 Suppl 2):S30-7. doi: 10.1053/j.ajkd.2007.12.012. Am J Kidney Dis. 2008. PMID: 18359406 - Testing for chronic kidney disease: a position statement from the National Kidney Foundation.
Vassalotti JA, Stevens LA, Levey AS. Vassalotti JA, et al. Am J Kidney Dis. 2007 Aug;50(2):169-80. doi: 10.1053/j.ajkd.2007.06.013. Am J Kidney Dis. 2007. PMID: 17660017 Review. - The epidemiology and control of anaemia among pre-ESRD patients with chronic kidney disease.
McClellan WM, Jurkovitz C, Abramson J. McClellan WM, et al. Eur J Clin Invest. 2005 Dec;35 Suppl 3:58-65. doi: 10.1111/j.1365-2362.2005.01532.x. Eur J Clin Invest. 2005. PMID: 16281960 Review.
Cited by
- Hemoglobin Glycation Index: A Novel Risk Factor for Incident Chronic Kidney Disease in an Apparently Healthy Population.
Nakasone Y, Miyakoshi T, Sakuma T, Toda S, Yamada Y, Oguchi T, Hirabayashi K, Koike H, Yamashita K, Aizawa T. Nakasone Y, et al. J Clin Endocrinol Metab. 2024 Feb 20;109(3):e1055-e1060. doi: 10.1210/clinem/dgad638. J Clin Endocrinol Metab. 2024. PMID: 37931239 Free PMC article. - An integrated machine learning predictive scheme for longitudinal laboratory data to evaluate the factors determining renal function changes in patients with different chronic kidney disease stages.
Tsai MH, Jhou MJ, Liu TC, Fang YW, Lu CJ. Tsai MH, et al. Front Med (Lausanne). 2023 Oct 4;10:1155426. doi: 10.3389/fmed.2023.1155426. eCollection 2023. Front Med (Lausanne). 2023. PMID: 37859858 Free PMC article. - Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for adults with early (stage 1 to 3) non-diabetic chronic kidney disease.
Cooper TE, Teng C, Tunnicliffe DJ, Cashmore BA, Strippoli GF. Cooper TE, et al. Cochrane Database Syst Rev. 2023 Jul 19;7(7):CD007751. doi: 10.1002/14651858.CD007751.pub3. Cochrane Database Syst Rev. 2023. PMID: 37466151 Free PMC article. Review. - Kannada Translation and Validation of the ESAS-r Renal for Symptom Burden Survey in Patients with End-Stage Kidney Disease.
Naik B, Nagaraju SP, Guddattu V, Salins N, Prabhu R, Damani A, Naik P, Rao KS, Rao IR, Singhai P. Naik B, et al. Indian J Palliat Care. 2023 Apr-Jun;29(2):195-199. doi: 10.25259/IJPC_216_2022. Epub 2023 May 30. Indian J Palliat Care. 2023. PMID: 37325264 Free PMC article. - Chronic Kidney Disease: Its Relationship With Obesity.
Prasad R, Jha RK, Keerti A. Prasad R, et al. Cureus. 2022 Oct 21;14(10):e30535. doi: 10.7759/cureus.30535. eCollection 2022 Oct. Cureus. 2022. PMID: 36415443 Free PMC article. Review.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical